Basit öğe kaydını göster

dc.contributor.authorSoyer, Tutku
dc.contributor.authorÖzyüksel, Gül
dc.contributor.authorTürer, Özlem Boybeyi
dc.contributor.authorÇakmakkaya, Kübra
dc.contributor.authorYavuz, Sinan
dc.contributor.authorYalçın, Bilgehan
dc.contributor.authorOrhan, Diclehan
dc.contributor.authorYalçın, Ebru
dc.contributor.authorDoğru, Deniz
dc.contributor.authorBayrakçı, Benan
dc.contributor.authorKiper, Nural
dc.contributor.authorAkyüz, Canan
dc.date.accessioned2021-06-03T06:15:41Z
dc.date.available2021-06-03T06:15:41Z
dc.date.issued2019
dc.identifier.issn2194-7619
dc.identifier.urihttp://dx.doi.org/10.1055/s-0039-1688771
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533102/
dc.identifier.urihttp://hdl.handle.net/11655/24231
dc.description.abstractBackground  Pulmonary Langerhans's cell histiocytosis (PLCH) is a rare cause of interstitial lung disease in children and more than half of the cases are bilateral. Persistent respiratory distress due to spontaneous pneumothorax (SP) in bilateral PLCH may refractory to conservative treatment and posed a great challenge to surgical modalities. A 3-year-old boy with SP due to bilateral PLCH is presented to discuss the surgical options of recurrent and refractory PLCH cases in children. , Case Report  The patient was admitted to the emergency department with severe respiratory distress and SP. After chest tube insertion, biopsy from neck mass revealed Langerhans's cell histiocytosis. Chemotherapy including vinblastine and prednisone was initiated. Due to persistent respiratory difficulty and air leaks, talc pleurodesis and thoracoscopic bullae excision with pleural decortication were performed. Two months after the admission, due to nosocomial infection and severe respiratory distress, extracorporeal membranous oxygenation (ECMO) support was initiated. The patient was died of ECMO complications on 24th day of ECMO. , Conclusion  Despite the use of chemotherapy and surgical excision of cystic lesions, bilateral PLCH in children may have lethal outcome. Other treatment options including respiratory support with ECMO and lung transplantation should be considered as last resort of treatment alternative in persistent cases.
dc.language.isoen
dc.relation.isversionof10.1055/s-0039-1688771
dc.rightsAttribution 4.0 United States
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleBilateral Pulmonary Langerhans'S Cell Histiocytosis Is Surgical Challenge In Children: A Case Report
dc.title.alternativeBilateral Pulmonary Langerhans's Cell Histiocytosis is Surgical Challenge in Children
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalEuropean Journal Of Pediatric Surgery Reports
dc.contributor.departmentÇocuk Cerrahisi
dc.identifier.volume7
dc.identifier.issue1
dc.description.indexPubMed
dc.description.indexWoS


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

Attribution 4.0 United States
Aksi belirtilmediği sürece bu öğenin lisansı: Attribution 4.0 United States